NICE guideline: Safe prescribing and withdrawal management of prescribed drugs associated with dependence and withdrawal

The final scope and equality impact assessment for this NICE guideline have now been published, along with all the stakeholder comments that were received during consultation and our responses to these comments.

NICE identified ARMA as a stakeholder for this topic and ARMA is able to comment on the draft guideline when it is available. Please contact us should you have an interest in this topic and are a member.

 

Comments are closed.